Trials / Conditions / Immune System Disorder

Immune System Disorder

27 registered clinical trials studyying Immune System Disorder — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure) NCT04430972	Barts & The London NHS Trust	—
Enrolling By Invitation	The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer NCT06540027	Başakşehir Çam & Sakura City Hospital	—
Completed	Hemogram Parameter Changes With Sepsis Filter NCT06948630	Samsun University	—
Unknown	Aerobic Training and Diet Protocol on Immune System in Burn Patients. NCT06141915	Cairo University	N/A
Completed	Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia P NCT06060509	Southeast University, China	N/A
Recruiting	Preterm Immune System Development and Response to Immunization NCT05266664	Maastricht University Medical Center	—
Recruiting	Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in NCT05507242	Asger Sverrild	Phase 2
Completed	A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy NCT05806567	Kadmon, a Sanofi Company	Phase 1
Unknown	Cross-condition Validation of the Steroid PRO NCT06314451	University of the West of England	—
Unknown	COVID-19 Post-Vaccination Observation NCT06107348	Yang I. Pachankis, PhD	—
Completed	Covid-19 Vaccine Responsiveness in MM and Waldenstrom NCT04830046	Massachusetts General Hospital	—
Unknown	COVID-19, Aging, and Cardiometabolic Risk Factors Study NCT04802044	Indonesia University	—
Unknown	Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly. NCT04928963	University of Genova	Phase 1 / Phase 2
Completed	Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection NCT05000307	University Hospital, Ghent	N/A
Unknown	PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort NCT04444609	Imperial College London	—
Terminated	Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation NCT04294459	Sanofi	Phase 1 / Phase 2
Completed	Pediatrics HOT COVID-19 Database in NY Tristate NCT04445402	Columbia University	—
Completed	Immune Changes in Severe COVID-19 Pulmonary Infections NCT04386395	Central Hospital, Nancy, France	—
Recruiting	Montreal Immune-Related Adverse Events (MIRAE) Study NCT05139706	Sir Mortimer B. Davis - Jewish General Hospital	—
Recruiting	Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation NCT03908736	University of New Mexico	N/A
Completed	A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymp NCT03744676	Juno Therapeutics, a Subsidiary of Celgene	Phase 2
Completed	The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis NCT03385850	Nanjing First Hospital, Nanjing Medical University	N/A
Recruiting	Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers NCT03207854	University of Southern California	—
Withdrawn	Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acid NCT05219890	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	N/A
Completed	Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects NCT03357939	Shanghai Henlius Biotech	Phase 1
Recruiting	PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and Immu NCT05002023	Universitätsklinikum Hamburg-Eppendorf	—
Completed	Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Com NCT00008450	Fred Hutchinson Cancer Center	Phase 1